Your browser doesn't support javascript.
loading
Downregulation of FAPP2 gene induces cell autophagy and inhibits PI3K/AKT/mTOR pathway in T-cell acute lymphoblastic leukemia.
Yuan, Tian; Wang, Jinhuan; Shi, Ce; Wang, Yi; Xia, Bing; Xu, Wen; Yang, Hongliang; Yang, Yaling; Ye, Matthew T; Khalid, Samah; Liang, Yong; Tian, Chen; You, M James; Wang, Yafei.
Afiliación
  • Yuan T; Key Laboratory of Cancer Immunology and Biotherapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
  • Wang J; Department of Oncology, Second Hospital of Tianjin Medical University, Institute of Urology, Tianjin, China.
  • Shi C; NHC Key Laboratory of Cell Transplantation, First Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang Province, China.
  • Wang Y; Key Laboratory of Cancer Immunology and Biotherapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
  • Xia B; Key Laboratory of Cancer Immunology and Biotherapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
  • Xu W; Key Laboratory of Cancer Immunology and Biotherapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
  • Yang H; Key Laboratory of Cancer Immunology and Biotherapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
  • Yang Y; NHC Key Laboratory of Cell Transplantation, First Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang Province, China.
  • Ye MT; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Khalid S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Liang Y; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Tian C; Department of Clinical Medicine, Taizhou University School of Medicine, Taizhou, Zhejiang Province, China.
  • You MJ; Key Laboratory of Cancer Immunology and Biotherapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
  • Wang Y; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Hematol Oncol ; 40(2): 249-257, 2022 Apr.
Article en En | MEDLINE | ID: mdl-34796518
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteínas Adaptadoras Transductoras de Señales / Proteínas Proto-Oncogénicas c-akt / Leucemia-Linfoma Linfoblástico de Células T Precursoras Límite: Humans Idioma: En Revista: Hematol Oncol Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteínas Adaptadoras Transductoras de Señales / Proteínas Proto-Oncogénicas c-akt / Leucemia-Linfoma Linfoblástico de Células T Precursoras Límite: Humans Idioma: En Revista: Hematol Oncol Año: 2022 Tipo del documento: Article País de afiliación: China